A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelCraig H. Moskowitz, Joachim Yahalom, Joseph R. Bertino et al.|Blood|2001Cited by 427
Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's LymphomaCraig H. Moskowitz, Andrew D. Zelenetz, Joseph R. Bertino et al.|Journal of Clinical Oncology|1999Cited by 303
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.David Wisniewski, Bayard D. Clarkson, Chongyuan Liu et al.|PubMed|2002Cited by 161
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Kenneth L. Scott, Turgut Dogruluk et al.|Nature Communications|2016Cited by 89
Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with ChemotherapyPhilip M. Tedeschi, Joseph R. Bertino|Molecular Pharmacology|2015Cited by 41